CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 273 enrolled
Drug / intervention
SmofKabiven emulsion for infusion +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03792100
NCT03792100Phase 3Completed

Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition (PN): A Randomized, Active-Controlled, Patient-blinded, Multi-Centre Study in Adult Surgical Patients Requiring PN

Fresenius Kabi·interventional·Posted Jan 3, 2019·Updated Aug 2, 2021

In Brief

A Phase 3 clinical trial evaluating SmofKabiven emulsion for infusion and Hospital compounded "All in one" emulsion for Parenteral Nutrition and Surgery. Completed, enrolled 273 participants across 8 sites.

Detailed Summary

The present protocol describes a randomized, patient-blinded study in which either SmofKabiven emulsion for infusion or a hospital compounded "All in one" control Total Parenteral Nutrition (TPN) regimen will be given to adult surgical patients for 5 consecutive days. As serum prealbumin is a well-established surrogate efficacy parameter reflecting the patient´s nutritional status, the change of the serum prealbumin level at the day of the final study visit compared to baseline will represent the primary efficacy parameter in the present study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
CollaboratorsParexel

Timeline

Phase 3CompletedFinished
20192020202120222023202420252026
First PostedJan 3, 2019
Enrollment StartJan 3, 2019
Primary CompletionJan 23, 2020
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 7.5 years ago

Interventions

SmofKabiven emulsion for infusiondrug

Total Parenteral Nutrition

Hospital compounded "All in one" emulsiondrug

Total Parenteral Nutrition